Axsome Therapeutics (FRA:19X) Accounts Payable : €49.5 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Axsome Therapeutics Accounts Payable?

Axsome Therapeutics's Accounts Payable for the quarter that ended in Mar. 2024 was €49.5 Mil.

Axsome Therapeutics's quarterly Accounts Payable increased from Sep. 2023 (€27.3 Mil) to Dec. 2023 (€37.3 Mil) and increased from Dec. 2023 (€37.3 Mil) to Mar. 2024 (€49.5 Mil).

Axsome Therapeutics's annual Accounts Payable increased from Dec. 2021 (€11.6 Mil) to Dec. 2022 (€36.4 Mil) and increased from Dec. 2022 (€36.4 Mil) to Dec. 2023 (€37.3 Mil).

Axsome Therapeutics Accounts Payable Historical Data

The historical data trend for Axsome Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axsome Therapeutics Accounts Payable Chart

Axsome Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

9.85

11.10

11.64

36.44

37.30

Axsome Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															33.41	39.65	27.27	37.30	49.49

Axsome Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Axsome Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Axsome Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Axsome Therapeutics (FRA:19X) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Axsome Therapeutics Inc (FRA:19X) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

AXSM:USA 19X:Germany

Address

22 Cortlandt Street, 16th Floor, New York, NY, USA, 10007

Website

https://www.axsome.com

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.

Axsome Therapeutics (FRA:19X) Headlines

No Headlines